It was into up cycle since the AGM. The yearly MA became good support.
broker, MB
Action and recommendation
• Upgrade to Outperform (from Neutral).
Earnings and target price revision
• FY21/22/2 EPS n.m./+24%/+14% driven by cost benefits/ op leverage. PT
upgraded to $20.00 (from $15.30), reflecting earnings changes & reduced
risk discount in FY24 (by 1/3) with vaccine rollout now underway.
It was into up cycle since the AGM. The yearly MA became good...
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.170(1.29%) |
Mkt cap ! $2.821B | |||
| Open | High | Low | Value | Volume |
| $13.13 | $13.17 | $12.81 | $8.978M | 694.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 4399 | $12.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.96 | 1455 | 20 |
View Market Depth
| Last trade - 15.34pm 26/08/2025 (20 minute delay) ? |
| FLT (ASX) Chart |